Logos Global Management LP

Position in TNGX — Tango Therapeutics, Inc.

CIK 1792126 San Francisco, CA

Position in TNGX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$89,091,000

+$26,331,000 QoQ

Shares Held

2,850,000

-5.0% QoQ

Ownership

1.69%

of shares outstanding

% of Portfolio

3.84%

of 13F equity value

Holder Rank

#22

of 246 holders

Holding Since

Sep 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Logos Global Management LP holds $2,281,179,823 across 63 Biotechnology names. TNGX ranks #7 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ERAS	Erasca, Inc.	12,150,000	$222,588,000
2	ABVX	Abivax S.A.	1,024,000	$136,458,240
3	RVMD	Revolution Medicines, Inc.	700,000	$131,096,000
4	IDYA	IDEAYA Biosciences, Inc.	3,000,000	$111,810,000
5	BNTX	BioNTech SE	1,015,000	$94,445,750
6	VERA	Vera Therapeutics, Inc.	2,200,000	$94,402,000
7	TNGX	Tango Therapeutics, Inc. This page	2,850,000	$89,091,000
8	PRAX	Praxis Precision Medicines, Inc.	260,000	$87,045,400

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$89,091,000	2,850,000	-5.0%	Shares	Sole	2026-08-14
2026-03-31	$62,760,000	3,000,000	-28.6%	Shares	Sole	2026-05-15
2025-12-31	$37,212,000	4,200,000	+342.1%	Shares	Sole	2026-02-17
2025-09-30	$7,980,000	950,000	—	Shares	Sole	2025-11-14
2021-06-30 BCTG	—	200,000	0.0%	Shares	Sole	2021-08-17
2021-03-31 BCTG	—	200,000	0.0%	Shares	Sole	2021-05-17
2020-12-31 BCTG	—	200,000	0.0%	Shares	Sole	2021-02-16
2020-09-30 BCTG	—	200,000	—	Shares	Sole	2020-11-17
No filing history on record for this holder in this stock.